Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT06993142
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage (Slow-SPEED)
Sponsor: 23andMe, Inc.
Conditions
Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Cerebral Disorder Genetic Predisposition Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Prodromal Stage Synucleinopathies
Interventions
Increase of physical activity volume and intensity with the use of a motivational smartphone application
Updated 1 time since 2025 Last updated: May 28, 2025 Started: Jul 1, 2025 Primary completion: Jun 30, 2029 Completion: Jun 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Basal Ganglia Diseases and Brain Diseases, this trial is actively recruiting participants. The trial is conducted by 23andMe, Inc. and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- 23andMe, Inc.
- Cure Parkinson's
- Davis Phinney Foundation
- Donders Centre for Cognitive Neuroimaging
- Edmond J. Safra Foundation
- Erasmus Medical Center
- Harvard School of Public Health (HSPH)
- Hoffmann-La Roche
- IJsfontein B.V., Netherlands
- Massachusetts General Hospital
- McGill University
- Michael J. Fox Foundation for Parkinson's Research
- Parkinson's Foundation
- Parkinson's UK
- Parkinsons Progression Markers Initiative (PPMI)
- Queen Mary University of London
- Radboud University Medical Center
- Sleep Medicine Centre Kempenhaeghe
- Sleep Medicine Centre SEIN
- Stichting ParkinsonNL
- University of Bristol
- University of Illinois at Chicago
- University of Luebeck
- University of Pittsburgh
- University of Plymouth
- University of Rochester
- ZonMw: The Netherlands Organisation for Health Research and Development
Data source: Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .